Table 1 Clinicopathologic characteristics of invasive lobular carcinoma cases

From: PD-L1 expression and the immune microenvironment in primary invasive lobular carcinomas of the breast

 

All cases

Phenotype

  

ER + /HER-2

ER + /HER-2 +

ER /HER-2 +

ER /HER-2

Total number (n)

47

33

8

1

5

Age (years)

 Mean (range)

59 (34–87)

58 (34–79)

62 (41–78)

87

62 (43–84)

Race

 White

37 (79%)

24 (73%)

8 (100%)

1 (100%)

4 (80%)

 Black

5 (11%)

5 (15%)

0 (0%)

0 (0%)

0 (0%)

 Asian

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

 Hispanic

3 (6%)

2 (6%)

0 (0%)

0 (0%)

1 (20%)

 Other

2 (4%)

2 (6%)

0 (0%)

0 (0%)

0 (0%)

Grade

 I

5 (11%)

4 (12%)

1 (13%)

0 (0%)

0 (0%)

 II

34 (72%)

27 (82%)

6 (74%)

0 (0%)

1 (20%)

 III

8 (17%)

2 (6%)

1 (13%)

1 (100%)

4 (80%)

Mean tumor size (cm)

2.8

2.7

2.7

7.1

3.2

Stage

 I

16 (34%)

16 (49%)

0 (0%)

0 (0%)

0 (0%)

 II

20 (43%)

10 (30%)

7 (87%)

0 (0%)

3 (60%)

 III

11 (23%)

7 (21%)

1 (13%)

1 (100%)

2 (40%)

 IV

0 (0%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Subsequent metastatic disease

 Yes

5 (11%)

1 (3%)

1 (13%)

1(100%)

2 (40%)

 No

42 (89%)

32 (97%)

7 (87%)

0 (0%)

3 (60%)

Death due to disease

 Yes

4 (9%)

1 (3%)

1 (13%)

0 (0%)

2 (40%)

 No

43 (91%)

32 (97%)

7 (87%)

1 (100%)

3 (60%)

  1. Abbreviations: HER-2, human epidermal growth factor 2; LCIS, lobular carcinoma in situ.